AN2 Therapeutics

About:

AN2 Therapeutics focuses on modern biomedical and drug development expertise to provide transformational medicines.

Website: https://www.an2therapeutics.com

Top Investors: Brii Biosciences, Bill & Melinda Gates Foundation, RA Capital Management, Frazier Life Sciences, TCG Crossover

Description:

AN2 Therapeutics, Inc. is a California-based global health biopharmaceutical company focused on modern biomedical and drug development expertise to provide transformational medicines for patients suffering from infectious diseases. The company was founded in 2017 and is headquartered in Menlo Park, California, United States.

Total Funding Amount:

$162M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2017-01-01

Founders:

Eric Easom, George Talbot, Joseph Zakrzewski, MIchael Alley

Number of Employees:

11-50

Last Funding Date:

2024-10-17

IPO Status:

Public

Industries: